questionsmedicales.fr
Acides aminés, peptides et protéines
Protéines
Protéines membranaires
Protéines de transport membranaire
Canaux ioniques
Canaux potassiques
Canaux potassiques voltage-dépendants
Canaux potassiques rectifiants retardés
Canaux potassiques KNCQ
Canal potassique KCNQ1
Canal potassique KCNQ1 : Questions médicales fréquentes
Termes MeSH sélectionnés :
Quantitative Structure-Activity Relationship
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Canal potassique KCNQ1 : Questions médicales les plus fréquentes",
"headline": "Canal potassique KCNQ1 : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Canal potassique KCNQ1 : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-06-11",
"dateModified": "2025-03-08",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Canal potassique KCNQ1"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Canaux potassiques KNCQ",
"url": "https://questionsmedicales.fr/mesh/D051656",
"about": {
"@type": "MedicalCondition",
"name": "Canaux potassiques KNCQ",
"code": {
"@type": "MedicalCode",
"code": "D051656",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.543.585.400.750.900.124.249"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Canal potassique KCNQ1",
"alternateName": "KCNQ1 Potassium Channel",
"code": {
"@type": "MedicalCode",
"code": "D051657",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Jodene Eldstrom",
"url": "https://questionsmedicales.fr/author/Jodene%20Eldstrom",
"affiliation": {
"@type": "Organization",
"name": "Department of Anesthesiology, Pharmacology & Therapeutics, The University of British Columbia, Vancouver, BC, Canada."
}
},
{
"@type": "Person",
"name": "David Fedida",
"url": "https://questionsmedicales.fr/author/David%20Fedida",
"affiliation": {
"@type": "Organization",
"name": "Department of Anesthesiology, Pharmacology & Therapeutics, The University of British Columbia, Vancouver, BC, Canada."
}
},
{
"@type": "Person",
"name": "Adam Szewczyk",
"url": "https://questionsmedicales.fr/author/Adam%20Szewczyk",
"affiliation": {
"@type": "Organization",
"name": "Laboratory of Intracellular Ion Channels, Nencki Institute of Experimental Biology, Polish Academy of Sciences, 02-093 Warsaw, Poland."
}
},
{
"@type": "Person",
"name": "Georg Kuenze",
"url": "https://questionsmedicales.fr/author/Georg%20Kuenze",
"affiliation": {
"@type": "Organization",
"name": "Center for Structural Biology, Vanderbilt University, Nashville, Tennessee, United States of America."
}
},
{
"@type": "Person",
"name": "Alfred L George",
"url": "https://questionsmedicales.fr/author/Alfred%20L%20George",
"affiliation": {
"@type": "Organization",
"name": "Department of Pharmacology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States of America."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Design, Synthesis, Antibacterial Evaluation, Three-Dimensional Quantitative Structure-Activity Relationship, and Mechanism of Novel Quinazolinone Derivatives.",
"datePublished": "2023-02-21",
"url": "https://questionsmedicales.fr/article/36807581",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1021/acs.jafc.2c07264"
}
},
{
"@type": "ScholarlyArticle",
"name": "Automated machine learning approach for developing a quantitative structure-activity relationship model for cardiac steroid inhibition of Na",
"datePublished": "2023-06-24",
"url": "https://questionsmedicales.fr/article/37354314",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s43440-023-00508-x"
}
},
{
"@type": "ScholarlyArticle",
"name": "Multivariate image analysis applied to quantitative structure-activity relationships and docking studies of recent hydroxyphenylpyruvate deoxygenase inhibitors.",
"datePublished": "2023-04-18",
"url": "https://questionsmedicales.fr/article/37021557",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/jsfa.12608"
}
},
{
"@type": "ScholarlyArticle",
"name": "Artificial Intelligence-Based Quantitative Structure-Property Relationship Model for Predicting Human Intestinal Absorption of Compounds with Serotonergic Activity.",
"datePublished": "2023-04-18",
"url": "https://questionsmedicales.fr/article/37070956",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1021/acs.molpharmaceut.2c01117"
}
},
{
"@type": "ScholarlyArticle",
"name": "Development of a quantitative structure-activity relationship model for predicting quantum yield of hydroxyl radical generation from organic compounds.",
"datePublished": "2023-01-25",
"url": "https://questionsmedicales.fr/article/36504232",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1039/d2em00396a"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Acides aminés, peptides et protéines",
"item": "https://questionsmedicales.fr/mesh/D000602"
},
{
"@type": "ListItem",
"position": 3,
"name": "Protéines",
"item": "https://questionsmedicales.fr/mesh/D011506"
},
{
"@type": "ListItem",
"position": 4,
"name": "Protéines membranaires",
"item": "https://questionsmedicales.fr/mesh/D008565"
},
{
"@type": "ListItem",
"position": 5,
"name": "Protéines de transport membranaire",
"item": "https://questionsmedicales.fr/mesh/D026901"
},
{
"@type": "ListItem",
"position": 6,
"name": "Canaux ioniques",
"item": "https://questionsmedicales.fr/mesh/D007473"
},
{
"@type": "ListItem",
"position": 7,
"name": "Canaux potassiques",
"item": "https://questionsmedicales.fr/mesh/D015221"
},
{
"@type": "ListItem",
"position": 8,
"name": "Canaux potassiques voltage-dépendants",
"item": "https://questionsmedicales.fr/mesh/D024642"
},
{
"@type": "ListItem",
"position": 9,
"name": "Canaux potassiques rectifiants retardés",
"item": "https://questionsmedicales.fr/mesh/D051668"
},
{
"@type": "ListItem",
"position": 10,
"name": "Canaux potassiques KNCQ",
"item": "https://questionsmedicales.fr/mesh/D051656"
},
{
"@type": "ListItem",
"position": 11,
"name": "Canal potassique KCNQ1",
"item": "https://questionsmedicales.fr/mesh/D051657"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Canal potassique KCNQ1 - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Canal potassique KCNQ1",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-12",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Canal potassique KCNQ1",
"description": "Comment diagnostiquer une dysfonction du canal KCNQ1 ?\nQuels tests sont utilisés pour évaluer KCNQ1 ?\nQuels symptômes indiquent un problème avec KCNQ1 ?\nLe diagnostic de KCNQ1 est-il basé sur des antécédents familiaux ?\nQuels spécialistes peuvent diagnostiquer des troubles KCNQ1 ?",
"url": "https://questionsmedicales.fr/mesh/D051657?mesh_terms=Quantitative+Structure-Activity+Relationship&page=3#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Canal potassique KCNQ1",
"description": "Quels sont les symptômes d'une mutation KCNQ1 ?\nLes symptômes de KCNQ1 varient selon l'âge ?\nComment les symptômes de KCNQ1 affectent-ils la vie quotidienne ?\nLes symptômes de KCNQ1 sont-ils toujours présents ?\nLes symptômes de KCNQ1 peuvent-ils s'aggraver avec le temps ?",
"url": "https://questionsmedicales.fr/mesh/D051657?mesh_terms=Quantitative+Structure-Activity+Relationship&page=3#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Canal potassique KCNQ1",
"description": "Comment prévenir les complications liées à KCNQ1 ?\nLes tests génétiques aident-ils à la prévention de KCNQ1 ?\nL'éducation des patients est-elle importante pour KCNQ1 ?\nLes activités physiques sont-elles sûres pour les patients KCNQ1 ?\nLes conseils diététiques peuvent-ils prévenir KCNQ1 ?",
"url": "https://questionsmedicales.fr/mesh/D051657?mesh_terms=Quantitative+Structure-Activity+Relationship&page=3#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Canal potassique KCNQ1",
"description": "Quels traitements sont disponibles pour les troubles KCNQ1 ?\nLa chirurgie est-elle une option pour KCNQ1 ?\nLes changements de mode de vie aident-ils avec KCNQ1 ?\nLes bêta-bloquants sont-ils efficaces pour KCNQ1 ?\nLes traitements sont-ils personnalisés pour KCNQ1 ?",
"url": "https://questionsmedicales.fr/mesh/D051657?mesh_terms=Quantitative+Structure-Activity+Relationship&page=3#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Canal potassique KCNQ1",
"description": "Quelles sont les complications possibles de KCNQ1 ?\nKCNQ1 peut-il entraîner des AVC ?\nLes complications de KCNQ1 sont-elles réversibles ?\nComment les complications de KCNQ1 sont-elles surveillées ?\nLes complications de KCNQ1 varient-elles selon les individus ?",
"url": "https://questionsmedicales.fr/mesh/D051657?mesh_terms=Quantitative+Structure-Activity+Relationship&page=3#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Canal potassique KCNQ1",
"description": "Quels sont les facteurs de risque pour KCNQ1 ?\nL'âge est-il un facteur de risque pour KCNQ1 ?\nLe stress peut-il aggraver KCNQ1 ?\nLes médicaments peuvent-ils influencer KCNQ1 ?\nLes habitudes de vie affectent-elles KCNQ1 ?",
"url": "https://questionsmedicales.fr/mesh/D051657?mesh_terms=Quantitative+Structure-Activity+Relationship&page=3#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une dysfonction du canal KCNQ1 ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un diagnostic peut inclure des tests génétiques et des électrocardiogrammes."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer KCNQ1 ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests incluent l'électrophysiologie et l'analyse génétique."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent un problème avec KCNQ1 ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes comme des palpitations ou des syncopes peuvent indiquer un problème."
}
},
{
"@type": "Question",
"name": "Le diagnostic de KCNQ1 est-il basé sur des antécédents familiaux ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les antécédents familiaux de troubles cardiaques sont importants."
}
},
{
"@type": "Question",
"name": "Quels spécialistes peuvent diagnostiquer des troubles KCNQ1 ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les cardiologues et les généticiens sont souvent impliqués dans le diagnostic."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une mutation KCNQ1 ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des arythmies, des évanouissements et des douleurs thoraciques."
}
},
{
"@type": "Question",
"name": "Les symptômes de KCNQ1 varient selon l'âge ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent varier, étant plus fréquents chez les jeunes adultes."
}
},
{
"@type": "Question",
"name": "Comment les symptômes de KCNQ1 affectent-ils la vie quotidienne ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils peuvent limiter l'activité physique et nécessiter une surveillance médicale."
}
},
{
"@type": "Question",
"name": "Les symptômes de KCNQ1 sont-ils toujours présents ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, certains patients peuvent être asymptomatiques malgré une mutation."
}
},
{
"@type": "Question",
"name": "Les symptômes de KCNQ1 peuvent-ils s'aggraver avec le temps ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, sans traitement, les symptômes peuvent s'aggraver avec l'âge."
}
},
{
"@type": "Question",
"name": "Comment prévenir les complications liées à KCNQ1 ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La surveillance régulière et le traitement précoce sont essentiels."
}
},
{
"@type": "Question",
"name": "Les tests génétiques aident-ils à la prévention de KCNQ1 ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les tests génétiques peuvent identifier les personnes à risque."
}
},
{
"@type": "Question",
"name": "L'éducation des patients est-elle importante pour KCNQ1 ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, comprendre la maladie aide les patients à gérer leurs symptômes."
}
},
{
"@type": "Question",
"name": "Les activités physiques sont-elles sûres pour les patients KCNQ1 ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Cela dépend de la gravité des symptômes; une évaluation médicale est nécessaire."
}
},
{
"@type": "Question",
"name": "Les conseils diététiques peuvent-ils prévenir KCNQ1 ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée peut contribuer à la santé cardiaque générale."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour les troubles KCNQ1 ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent des médicaments antiarythmiques et des dispositifs implantables."
}
},
{
"@type": "Question",
"name": "La chirurgie est-elle une option pour KCNQ1 ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la chirurgie peut être envisagée dans les cas graves d'arythmies."
}
},
{
"@type": "Question",
"name": "Les changements de mode de vie aident-ils avec KCNQ1 ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, éviter le stress et adopter une alimentation saine peuvent aider."
}
},
{
"@type": "Question",
"name": "Les bêta-bloquants sont-ils efficaces pour KCNQ1 ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les bêta-bloquants peuvent aider à contrôler les arythmies."
}
},
{
"@type": "Question",
"name": "Les traitements sont-ils personnalisés pour KCNQ1 ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les traitements sont souvent adaptés en fonction des symptômes et des antécédents."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications possibles de KCNQ1 ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des arythmies graves et un risque accru de mort subite."
}
},
{
"@type": "Question",
"name": "KCNQ1 peut-il entraîner des AVC ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des arythmies peuvent augmenter le risque d'accidents vasculaires cérébraux."
}
},
{
"@type": "Question",
"name": "Les complications de KCNQ1 sont-elles réversibles ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être gérées, mais d'autres peuvent être permanentes."
}
},
{
"@type": "Question",
"name": "Comment les complications de KCNQ1 sont-elles surveillées ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles sont surveillées par des examens réguliers et des tests de fonction cardiaque."
}
},
{
"@type": "Question",
"name": "Les complications de KCNQ1 varient-elles selon les individus ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la gravité et le type de complications peuvent varier d'une personne à l'autre."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque pour KCNQ1 ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent des antécédents familiaux, des maladies cardiaques et des médicaments."
}
},
{
"@type": "Question",
"name": "L'âge est-il un facteur de risque pour KCNQ1 ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le risque augmente souvent avec l'âge, surtout chez les hommes."
}
},
{
"@type": "Question",
"name": "Le stress peut-il aggraver KCNQ1 ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress peut déclencher ou aggraver les symptômes d'arythmie."
}
},
{
"@type": "Question",
"name": "Les médicaments peuvent-ils influencer KCNQ1 ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains médicaments peuvent interférer avec la fonction du canal KCNQ1."
}
},
{
"@type": "Question",
"name": "Les habitudes de vie affectent-elles KCNQ1 ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des habitudes de vie saines peuvent réduire le risque de complications."
}
}
]
}
]
}
Plant bacterial illnesses are common and cause dramatic damage to agricultural goods all over the world, yet there are few efficient bactericides to alleviate them at present. To discover novel antiba...
Quantitative structure-activity relationship (QSAR) modeling is a method of characterizing the relationship between chemical structures and biological activity. Automated machine learning enables comp...
The chemical structures and inhibitory activities of 215 CS derivatives were obtained from the scientific literature. Predictive QSAR models were constructed using molecular descriptors, fingerprints,...
The best predictive QSAR models were selected based on the LogLoss value. Using these models, the Matthews correlation coefficient, F1 score, and area under the curve of the test dataset were 0.6729, ...
The automated machine learning-based QSAR method developed here should be applicable for the time-efficient construction of predictive models using only a small number of compounds....
Mesotrione is a triketone widely used as an inhibitor of the hydroxyphenylpyruvate deoxygenase (HPPD) enzyme. However, new agrochemicals should be developed continuously to tackle the problem of herbi...
The MIA-QSAR models based on van der Waals radii (r...
Multivariate image analysis descriptors corroborated by docking studies were capable of modeling the herbicidal activities of 68 triketones reliably. Due to the substituent effects at the triketone fr...
Oral medicines represent the largest pharmaceutical market area. To achieve a therapeutic effect, a drug must penetrate the intestinal walls, the main absorption site for orally delivered active pharm...
Organic compounds are capable of generating hydroxyl radicals (˙OH) through their excited triplet states in natural water. It is of significance to reveal the underlying mechanism of the generation an...
Fungal genera Alternaria and Fusarium include human and plant pathogenic species. Several antifungals have been used for their control, but excessive use has contributed to resistance development in p...
To evaluate in vitro and in silico the antifungal activities of terpenoids against Alternaria alternata and Fusarium oxysporum....
The minimum inhibitory concentration and minimum fungicidal concentration values of 27 constituents of essential oils used against Alternaria alternata and Fusarium oxysporum were evaluated in vitro. ...
The evaluated compounds proved to be effective antifungals. Thymol was the most active with a minimum inhibitory concentration of 91.6 ± 28.8 μg/ml for A. alternata and F. oxysporum. Quantitative stru...
Terpenoids exhibit relevant antifungal activities that should be incorporated into the study of medicinal chemistry. Inclusion of in silico assays in the in vitro evaluation is a valuable tool in the ...
Currently, increasing availability and popularity of designer benzodiazepines (DBZDs) constitutes a primary threat to public health. To assess this threat, the biological activity/potency of DBZDs was...
3D-QSAR models were established by collecting 46 multivariate-substituted 4-oxyquinazoline HDAC6 inhibitors. The relationship of molecular structure and inhibitory activity was studied by comparative ...
The leading cause of atherosclerotic cardiovascular disease (ASCVD) is elevated low-density lipoprotein cholesterol (LDL-C). Proprotein convertase subtilisin/kexin type 9 (PCSK9) attaches to the domai...
A positron emission tomography (PET) radioligand for imaging phosphodiesterase 4D (PDE4D) would benefit drug discovery and the investigation of neuropsychiatric disorders. The most promising radioliga...